EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Approach to the Diagnosis and Management of Primary Hyperparathyroidism

Layana Tyara Sandes Fraga, Carlo Augusto Cicchetto Basílio, Monique Nakayama Ohe

Diagnostics · 20.11.2026 · 16 (22) · 3900

DOI: 10.3390/diagnostics16223900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 20.11.2026. Verfasst von Layana Tyara Sandes Fraga und 2 weiteren Autor:innen. Die Arbeit nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary hyperparathyroidism (PHPT) is a common endocrine disorder and an important cause of secondary osteoporosis, characterized by excessive or inappropriate parathyroid hormone secretion relative to serum calcium concentrations. Although its clinical presentation has shifted toward asymptomatic and mild biochemical phenotypes, skeletal and renal complications remain clinically relevant and may be overlooked. This narrative review discusses the diagnosis and management of PHPT, emphasizing diagnostic pitfalls, hereditary forms, and skeletal involvement. Biochemical assessment requires careful interpretation of calcium and parathyroid hormone measurements, recognition of preanalytical and immunoassay interference, and differentiation from familial hypocalciuric hypercalcemia and secondary causes of elevated parathyroid hormone. Normocalcemic PHPT requires rigorous exclusion of secondary hyperparathyroidism, and evidence guiding its treatment remains limited. Skeletal manifestations range from reduced bone mineral density and impaired cortical and trabecular microarchitecture to osteitis fibrosa cystica, brown tumors, and pathological fractures. Dual-energy X-ray absorptiometry, vertebral fracture assessment, and complementary tools such as trabecular bone score help characterize skeletal involvement beyond bone mass alone. Genetic evaluation in selected patients informs surgical planning, surveillance, and family screening. Parathyroidectomy remains the only curative treatment, whereas localization imaging serves surgical planning rather than diagnostic confirmation. For patients managed without surgery, antiresorptive agents improve bone mineral density, while cinacalcet controls hypercalcemia. Integrating accurate biochemical diagnosis, skeletal and renal assessment, and recognition of hereditary disease supports individualized management and helps avoid unnecessary investigations and inappropriate interventions.

Zitieren

APA

Fraga, L. T. S., Basílio, C. A. C., & Ohe, M. N. (2026). Approach to the Diagnosis and Management of Primary Hyperparathyroidism. Diagnostics, 16(22), 3900. https://doi.org/10.3390/diagnostics16223900

Vancouver

Fraga LTS, Basílio CAC, Ohe MN. Approach to the Diagnosis and Management of Primary Hyperparathyroidism. Diagnostics. 2026;16(22):3900. doi:10.3390/diagnostics16223900

BibTeX
@article{Fraga2026,
  author = {Fraga, Layana Tyara Sandes and Basílio, Carlo Augusto Cicchetto and Ohe, Monique Nakayama},
  title = {Approach to the Diagnosis and Management of Primary Hyperparathyroidism},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {22},
  pages = {3900},
  doi = {10.3390/diagnostics16223900}
}
Kostenlos starten →